Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

The current macro environment appears grim, given the uncertainty around the global trade war, along with ongoing ...

Story March 20 - Elevation Oncology: The biotech is ditching its sole clinical-stage asset in the wake of disappointing phase 1 data and laying off 70% of its staff as a result. The restructuring ...

Apollomics has tagged out of its partnership with TYG Oncology, terminating an immuno-oncology pact as part of a push to cut ...

We, like so many others, have been forced to take steps to extend our cash runway,” said Tango’s CEO, citing the “extremely challenging financial markets.” ...

We recently published a list of 7 Most Profitable Biotech Stocks To Buy Right Now. In this article, we are going to take a ...

The 61-year-old pilot killed in a small plane crash over the weekend in New Jersey was the CEO of an oncology-focused biotech ...

New facility is expected to serve as a global hub for accelerating the development of next-generation antibody-drug ...

We recently published a list of 10 Hot Biotech Stocks Under $5. In this article, we are going to take a look at where Cardiff ...

US oncology biotech Inspirna is winding down after a decade of operations, according to a LinkedIn post from chief executive Usman Azam. He said the New York-based company would close after “ten ...

Cellular Therapies and IDRx, crossed the $1 billion mark, a notable decrease from the six seen during the same period last ...

Other pharmaceutical and health care companies recently announced layoffs — including Bayer, Siemens, RWJBarnabas Health and ...